Bachem Holding AGBCHMF 91 Market Cap is $6,509.8 Mil as of Jun. 25, 2026. GuruFocus rates BCHMF with a GF Score™ of 91/100 and a GF Value™ of $98.14 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,430 Biotechnology companies, Bachem Holding AG ranks better than 95.87% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bachem Holding AG's share price for the quarter that ended in Dec. 2025 was $60.51. Bachem Holding AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 74.9 Mil. Therefore, Bachem Holding AG's market cap for the quarter that ended in Dec. 2025 was $4,534.4 Mil.
Bachem Holding AG's quarterly market cap
declined
from Dec. 2024 ($4,723.2 Mil) to Jun. 2025 ($4,605.7 Mil) and
declined
from Jun. 2025 ($4,605.7 Mil) to Dec. 2025 ($4,534.4 Mil).
Bachem Holding AG's annual market cap
declined
from Dec. 2023 ($6,365.3 Mil) to Dec. 2024 ($4,723.2 Mil) and
declined
from Dec. 2024 ($4,723.2 Mil) to Dec. 2025 ($4,534.4 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bachem Holding AG's Enterprise Value for Today is $6,154.2 Mil.
Bachem Holding AG (OTCPK:BCHMF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bachem Holding AG Market Cap Related Terms
Bachem Holding AG Market Cap Historical Data
* Premium members only.
The historical data trend for Bachem Holding AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Bachem Holding AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bachem Holding AG Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bachem Holding AG's Market Cap distribution charts can be found below:
* The bar in red indicates where Bachem Holding AG's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bachem Holding AG's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bachem Holding AG (BCHMF) has a Market Cap of $6,509.8 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bachem Holding AG and its competitors. According to the industry distribution chart, Bachem Holding AG ranks #59 out of 1430 companies in the Biotechnology industry, placing it in the top 4.1%.
Is Bachem Holding AG's Market Cap too high?
Bachem Holding AG's current Market Cap is $6,509.8 Mil. The Biotechnology industry median Market Cap is 117.26. Bachem Holding AG's value of $6,509.8 Mil is 5451.5% above this industry median. Based on the distribution chart, Bachem Holding AG ranks #59 out of 1430 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bachem Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #59 out of 1430 companies for Market Cap. This places Bachem Holding AG in the top 4% of its industry — outperforming the majority of peers. The industry median Market Cap is 117.26. Bachem Holding AG's value of $6,509.8 Mil is 5451.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.26, based on 1,430 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bachem Holding AG's current Market Cap of $6,509.8 Mil is 5451.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bachem Holding AG and its competitors. For the Biotechnology industry, the median Market Cap is 117.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bachem Holding AG's current Market Cap is $6,509.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.14, compared to a current price of $87.34 — trading 11% below its estimated fair value. The current Market Cap is $6,509.8 Mil and 5451.5% above the Biotechnology industry median of 117.26. Bachem Holding AG's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current Market Cap is $6,509.8 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bachem Holding AG (BCHMF) Overvalued in 2026?
Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued.
The current stock price of $87.34 is trading 11% below its estimated GF Value™ of $98.14.
GuruFocus considers Bachem Holding AG to be Modestly Undervalued.
Key valuation signals for BCHMF:
Market Cap: $6,509.8 Mil
GF Value™: $98.14 vs. price of $87.34 (11% below fair value)
Industry Position: 5451.5% above the Biotechnology median (#59 of 1430)
No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
91GF Score
Get the complete analysis for BCHMF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCHMF has been successfully added to your 
